FR314F - - Google Patents

Info

Publication number
FR314F
FR314F FR144905A FR144905A FR314F FR 314 F FR314 F FR 314F FR 144905 A FR144905 A FR 144905A FR 144905 A FR144905 A FR 144905A FR 314 F FR314 F FR 314F
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR144905A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to FR144905A priority Critical patent/FR314F/fr
Priority to BE729914D priority patent/BE729914A/xx
Priority to GB1380069A priority patent/GB1196229A/en
Priority to DE19691914456 priority patent/DE1914456A1/de
Application granted granted Critical
Publication of FR314F publication Critical patent/FR314F/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18—Aralkyl radicals
    • C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR144905A 1968-03-22 1968-03-22 Expired FR314F (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR144905A FR314F (fr) 1968-03-22 1968-03-22
BE729914D BE729914A (fr) 1968-03-22 1969-03-14
GB1380069A GB1196229A (en) 1968-03-22 1969-03-17 Improvements in or relating to a New Glyoxylic Acid Salt, process for its preparation and Therapeutical Composition containing same
DE19691914456 DE1914456A1 (de) 1968-03-22 1969-03-21 Papaveringlyoxylat,seine Herstellung und Verwendung

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR144905A FR314F (fr) 1968-03-22 1968-03-22

Publications (1)

Publication Number Publication Date
FR314F true FR314F (fr) 1970-05-25

Family

ID=8647868

Family Applications (1)

Application Number Title Priority Date Filing Date
FR144905A Expired FR314F (fr) 1968-03-22 1968-03-22

Country Status (4)

Country Link
BE (1) BE729914A (fr)
DE (1) DE1914456A1 (fr)
FR (1) FR314F (fr)
GB (1) GB1196229A (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE028976T2 (en) 2003-06-17 2017-02-28 Arena Pharm Inc 8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride
CN1805939B (zh) 2003-06-17 2010-10-13 艾尼纳制药公司 用于治疗5ht2c受体相关病症的苯并氮杂卓衍生物
KR20130087622A (ko) 2004-12-23 2013-08-06 아레나 파마슈티칼스, 인크. 5ｈｔ２ｃ 수용체 조정물질 조성물 및 그의 사용 방법
WO2007120517A2 (fr) 2006-04-03 2007-10-25 Arena Pharmaceuticals, Inc. Procédés de préparation de 8-chloro-1-méthyl-2,3,4,5-tétrahydro-1h-3-benzazépine et produits intermédiaires associés
EP2099743B1 (fr) 2006-12-05 2014-08-27 Arena Pharmaceuticals, Inc. Procédés de préparation de (r)-8-chloro-1-méthyl-2,3,4,5-tétrahydro-1h-3-benzazépine et intermédiaires de celle-ci
US8822727B2 (en) 2008-03-04 2014-09-02 Arena Pharmaceuticals, Inc. Processes for the preparation of intermediates related to the 5-HT2C agonist (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
CN102648170A (zh) 2009-06-18 2012-08-22 艾尼纳制药公司 制备5-ht2c受体激动剂的方法
US9045431B2 (en) 2010-06-02 2015-06-02 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
US9365521B2 (en) 2010-09-01 2016-06-14 Arena Pharmaceuticals, Inc. Non-hygroscopic salts of 5-HT2C agonists
SG188362A1 (en) 2010-09-01 2013-04-30 Arena Pharm Inc Modified-release dosage forms of 5-ht2c agonists useful for weight management
EA201390335A1 (ru) 2010-09-01 2013-09-30 Арена Фармасьютикалз, Инк. Введение лоркасерина индивидуумам с почечной недостаточностью
WO2012030938A1 (fr) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Sels de lorcasérine dotés d'acides optiquement actifs
WO2014058441A1 (fr) 2012-10-09 2014-04-17 Arena Pharmaceuticals, Inc. Procédé de gestion du poids

Also Published As

Publication number Publication date
BE729914A (fr) 1969-09-15
GB1196229A (en) 1970-06-24
DE1914456A1 (de) 1971-06-16

Similar Documents

Publication Publication Date Title
AU1946070A (fr)
AU2374870A (fr)
FR314F (fr)
AU429879B2 (fr)
AU416157B2 (fr)
AU2581067A (fr)
AU421558B1 (fr)
AU3224368A (fr)
AU3789668A (fr)
AU2580267A (fr)
AU4744468A (fr)
AR203075Q (fr)
AU463027A (fr)
BE727043A (fr)
BE727034A (fr)
BE728646A (fr)
BE726063A (fr)
BE724109A (fr)
BE714016A (fr)
BE709496A (fr)
BE728705A (fr)
BE727380A (fr)
BE709119A (fr)
AU4224469A (fr)
BE728616A (fr)